Anti-tubercular activity of isatin derivatives

International Journal of Research in Pharmaceutical Sciences

Volumn 1, Issue 2, 2010, Pages 113-126

  Aboul Fadl, Tarek ^a   Bin Jubair, Fayzah A S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anti tubercular; Indoline 2,3 dione; Isatin; Isatin derivatives; Tuberculosis

Indexed keywords

5 (3' METHYLBUTEN 2' YL) ISATIN; 6 (3' METHYLBUTEN 2' YL) ISATIN; AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; INDOLINE 2,3 DIONE; ISATIN DERIVATIVE; ISONIAZID; KANAMYCIN; METISAZONE; NATURAL PRODUCT; PROTIONAMIDE; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TRYPTANTHRIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; ENVIRONMENT; HOST CELL; MULTIDRUG RESISTANT TUBERCULOSIS; REVIEW;

EID: 77954574682     PISSN: None     EISSN: 09757538     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Aboul-Fadl T, Mohammed FA, Hassan EA. Synthesis, Antitubercular Activity and Pharmacokinetic Studies of Some Schiff Bases Derived from 1-Alkylisatin and Isonicotinic Acid Hydrazide (INH). Arch. Pharm. Res. 2003, 26: 778-784.
2. Bal TR, Anand B, Yogeeswari P, Sriram D. Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett. 2005, 15: 4451-4455.
3. Ballell L, Field RA, Duncan K, Young RJ. New small-molecule synthetic antimycobacterials. Antimicrob. Agents Chemother. 2005, 49: 2153-2163.
4. Bergman J, Lindström JO, Tilstam U. The structure and properties of some indolic constituents in Couroupita guianensis aubl. Tetrahedron 1985, 41: 2879-2881.
5. Berry M, Kon OM. Multidrug-and extensively drug-resistant tuberculosis: an emerging threat. Eur. Respir. Rev. 2009, 18:195-197.
6. Breinholt J, Demuth H, Heide M, Jensen GW, Moeller IL, Nielsen RI, Olsen CE, Rosendahl CN. Prenisatin (5-(3-methyl-2-butenyl)indole-2,3-dione): an antifungal isatin derivative from Chaetomium globosum. Acta Chem. Scand. 1996, 50: 443.
7. Chiyanzu I, Clarkson C, Smith PJ, Lehman J, Gut J, Rosenthalc PJ, Chibalea K. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. Bioorg. Med. Chem. 2005, 13, 3249-3261.
8. Cocco MT, Congiu C, Onnis V, Pusceddu MC, Schivo ML, Logu A. Synthesis and antimycobacterial activity of some isonicotinoylhydrazones. Eur. J. Med. Chem. 1999, 34: 1071-1076.
9. Da Silva JFM, Garden SJ, Pinto AC. The Chemistry of Isatins: a Review from 1975 to 1999. J. Braz. Chem. Soc. 2001, 12: 273-324.
10. th Ed. New York, McGraw-Hill 1991, 637.
11. De Souza MVN. Current status and future prospects for new therapies for pulmonary tuberculosis. Curr. Opin. Pulm. Med. 2006, 12: 167-171.
12. De Souza MVN. Promising Drugs Against Tuberculosis. Recent Pat. Anti-Infect. Drug Discovery 2006, 1: 33-44.
13. Duncan K, Barry CE. Prospects for new antitubercular drugs. Curr. Opin. Microbiol. 2004, 7:460-465.
14. El-Sawi EA, Mostaza TB, Mostaza BB. Studies on the molluscicidal action of some isatin derivatives against Biomphalaria alexandrina in Egypt. J. Egypt. Soc. Parasitol. 1998, 28: 481-486.
15. Fedchenko V, Globa A, Kaloshin A, Kapitsa I, Nerobkova L, Val'dman E, Buneeva O, Glover V, Medvedev A. The effect of short-term administration of (-)-deprenyl and isatin on the expressions of some genes in the mouse brain cortex. Med. Sci. Monit. 2008, 14: 69-73.
16. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. The Lancet 2003, 362: 887-899.
17. Gaston MA, Dias LRS, Freitas ACC, Miranda ALP, Barreiro EJ. Synthesis and analgesic properties of new 4-arylhydrazone 1-H pyrazole [3,4-b] pyridine derivatives. Pharmac. Acta Helvet. 1996, 71: 213-219.
18. Glickman SW, Rasiel EB, Hamilton CD, Kubataev A, Schulman KA. A portfolio model of drug development for tuberculosis. Science 2006, 311: 1246-1247.
19. Grafe U, Radics L. Isolation and structure elucidation of 6-(3'-methylbuten-2'-yl)isatin, an unusual metabolite from Streptomyces albus. J. Antibiotics 1986 (a), 39: 162-163
20. Graefe U, Schade W, Fleck W. Microbial manufacture of 6-(3'-methylbuten-2',3'-yl)-isatine. 1986 (b), Ger (East) DD 241,749. (CA 107:P216174k)
21. Güzel Ö, Karali N, Salman, A. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives. Bioorg. Med. Chem. 2008, 16: 8976-8987.
22. Guo Y, Chen F. TLC-UV-spectrophotometric and TLC-scanning determination of isatin in leaf of Isatis. Zhongcaoyao 1986, 17: 8-11. (CA 104:213068f)
23. Halket JM, Watkins PJ, Przyborowska A, Goodwin BL, Clow A, Glover V, Sandler M. Isatin (indole-2,3-dione) in urine and tissues: Detection and determination by gas chromatography-mass spectrometry. Journal of Chromatography: Biomedical Applications 1991, 562: 279-287.
24. Holla BS, Rao BS, Shridhara K, Akberali PM. Studies on arylfuran derivatives. Part XI. Synthesis, characterization and biological studies on some Mannich base carrying 2, 4-dichlorophenylfurfural moiety. Farmaco 2000, 55:338-344.
25. Hung TV, Dat NQ, Van LN, Tap LT. Study on the antitu-berculosis effect of some thiosemicarbazone and isonicotinoylhydrazone derivatives of isatin and 5-halogeno-isatin. Tap Chi Duoc Hoc 2000, 15-17.
26. Hussein MA, Aboul-Fadl T, Hussein A. Synthesis and Antitubercular Activity of Some Mannich Bases Derived From Isatin Isonicotinic Acid Hydrazone. Bull. Pharm. Sci., Assiut University 2005, 28:131-136.
27. Imam SA, Varma RS. Isatin-3-anils as excystment and cysticidal agents against Schizopyrenus russelli. Experientia 1975, 31:1287-1288.
28. Ischia M, Palum A, Prota G. Adrenalin oxidation revisited. New products beyond the adrenochrome stage. Tetrahedron 1988, 44: 6441-6446.
29. Janin YL. Antituberculosis drugs: Ten years of research. Bioorg. Med. Chem. 2007, 15: 2479 2513.
30. Kapadia GJ, Shukla YN, Basak SP, Sokoloski EA, Fales HM. The melosatins-a novel class of alkaloids from melochia tomentosa. Tetrahedron 1980, 36: 2441-2447.
31. Kapadia GJ, Shukla YN, Chowdhury BK, Basak SP, Fales HM, Sokoloski EA. Phenylpentylisatins: a novel class of alkaloids from Melochia tomentosa. J. Chem. Soc., Chem. Commun. 1977, 535-536.
32. Kapadia GJ, Shukla, YN. Melosatin D: A New Isatin Alkaloid from Melochia tomentosa Roots. Planta Med. 1993, 59: 568-569.
33. Karah N, Terzioglu N, Gursoy A. Synthesis and structure-activity relationships of 3-hydrazono-1H-2-indolinones with antituberculosis activity. Arzneimittel-Forschung 1998, 48: 758-763.
34. Karali N, Gürsoy A, Kandemirli F, Shvets N, Kaynak FB, Özbey S, Kovalishyn V, Dimoglo A. Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg. Med. Chem. 2007, 15: 5888-5904.
35. Karali N, Kocabalkanli A, Gürsoy A, Ateş Ö. Synthesis and antitubercular activity of 4-(3-coumarinyl)-3-cyclohexyl-4-thiazolin-2-one benzylidenehydrazones. II Farmaco 2002, 57: 589-593.
36. Kaymakçioǧlu BK, Rollas S. Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones. II Farmaco 2002, 57: 595-599.
37. Küçükgüzel SG, Mazi A, Sahin F, Öztürk S, Stables J. Synthesis and biological activities of diflunisal hydrazide-hydrazones. Eur. J. Med. Chem. 2003, 38: 1005-1013.
38. Küçükgüzel SG, Rollas S, Küçükgüzel I, Kiraz M. Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur. J. Med. Chem. 1999, 34:1093-1100.
39. Kumar RR, Perumal S, Senthilkumar P, Yogeeswari P, Sriram D. Discovery of Antimycobacterial Spiro-piperidin-4-ones: An Atom Economic, Stereoselective Synthesis, and Biological Intervention. J. Med. Chem. 2008, 51: 5731-5735.
40. Lemke TL. Antimycobacterial agents; In: Foye WO, Lemke TL, Williams DA. eds. Principles of Medicinal Chemistry 4th ED. 1995, pp. 747-758.
41. Logan JC, Fox MP, Morgan JH, Makohon AM, Pfau CJ. Arenavirus inactivation on contact with N-substituted isatin β-thiosemicarbazones and certain cations. J. Gen. Virol. 1975, 28: 271-283.
42. Loncle C, Brunel JM, Vidal N, Dherbomez M, Letourneux Y. Synthesis and antifungal activity of choles-terol-hydrazone derivatives. Eur. J. Med. Chem. 2004, 39:1067-1071.
43. Lourenço MCDS, Ferreira MDL, De Souza MVN, Peralta MA, Vasconcelos TRA, Henriques MDGMO. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted benzylidene) isonicotinohydrazide derivatives. Eur. J. Med. Chem. 2008, 43:1344-1347.
44. Maccari R, Ottanà R, Vigorita MG. In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14. Bioorg. Med. Chem. Lett. 2005, 15: 2509-2513.
45. Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat. Med. 2000, 6:1327-1329.
46. Marwick C, Do worldwide outbreaks mean tuberculosis again becomes 'captain of all these men of death'? JAMA 1992, 257: 1174-1175.
47. Mehta DK, Martin J, Jordan B, Macfarlane CR, Ryan RSM, Wagle SMS, Hashmi FT, Kakar S, Kouimtzi M, Masieh D, Radia HCG, Sharma VK, Shing T, Gallagher GP. eds. Antituberculous drugs In: British National Formulary. 2003, pp. 283-287.
48. Melnyk P, Leroux V, Sergheraert C, Grellier P. Design, synthesis and in vitro antimalarial activity of an acylhydrazone library. Bioorg. Med. Chem. Lett. 2006, 16: 31-35.
49. Mitscher LA, Baker WR. A search for novel chemotherapy against tuberculosis amongst natural products. Pure & Appl. Chem. 1998, 70: 365-371.
50. Pal R, Jain K, Gupta GD, Handa RN, Puzari HK. Synthetic methods using isatin and derivatives. Indian J Chem. 19991, 30B: 1098.
51. Palumbo A, D'Ischia M, Misuraca G, Prota G. A new look at the rearrangement of adrenochrome under biomimetic conditions. Biochim. Biophys. Acta 1989, 990: 297-302.
52. Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole. Arzneim. Forsch. /Drug Res. 2000, 50: 55-59.
53. Pandeya SN, Smitha S, Jyoti M, Sridhar SK. Biological activities of isatin and its derivatives. Acta Pharm. 2005, 55: 27-46.
54. Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur. J. Pharm. Sci. 1999, 9: 25-31.
55. Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV activities of Norfloxacin Mannich bases. Eur. J. Med. Chem. 2000, 35: 249-255.
56. Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine. Farmaco 1999, 54: 624-628.
57. Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV activity of Schiff and Mannich bases of isatin with N-[6-chlorobenzthiazole-2-yl] thiosemicarbazide. Indian J. Pharm. Sci.1999, 61: 358-361.
58. Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. Pharm. Acta Helv. 1999, 74: 11-17.
59. Pandeya SN, Sriram D. Synthesis and screening for antibacterial activity of Schiff's and Mannich bases of Isatin and its derivatives. Acta. Pharm. Turc. 1998, 40:33-38.
60. Pandeya SN, Yogeeswari P, Sriram D, De Clercq E, Pannecouque C, Witvrouw M. Synthesis and Screening for Anti-HIV Activity of Some N-Mannich Bases of Isatin Derivatives. Chemotherapy 1999, 45: 192-196.
61. Pandeya SN, Yogeeswari P, Sriram D, Nath G. Synthesis and antimicrobial activity of N-Mannich bases of 3-[N′ -sulphadooximino]isatin and its methyl derivatives. Bull. Chim. Farm. 1998, 137: 321-324.
62. Papakonstantinou-Garoufalias S, Pouli N, Marakos P, Chytyroglou-Ladas A. Synthesis antimicrobial and antifungal activity of some new 3-substituted derivatives of 4-(2,4-dichlorophenyl)-5-adamantyl-1H-1,2,4-triazole. II Farmaco 2002, 57: 973-977.
63. Parrish NM, Dick JD. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998, 6:107-112.
64. Patole J, Sandbhor U, Padhye S, Deobagkar DN, Anson CE, Powell A. Structural chemistry and In vitro antitubercular activity of acetylpyridine benzoyl hydra-zone and its copper complex against Mycobacterium smegmatis. Bioorg. Med. Chem. Lett. 2003, 13:51-55.
65. Peloquin CA, Berning SE. Infection caused by Mycobacterium tuberculosis. Ann. Pharmacother. 1994, 28: 72.
66. Petri WA, Antimicrobial agents, Drugs used in the chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy; In: Hardman JG, Limbird LE, Goodman A. eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th ED. 2001, pp. 1273-1294
67. Pirrung MC, Pansare SV, Das Sarma K, Keith KA, Kern ER. Combinatorial Optimization of Isatin-β-Thiosemicarbazones as Anti-poxvirus Agents. J. Med. Chem. 2005, 48: 3045.
68. Popp FD. Potential anticonvulsant. XII. Anticonvulsant activity of some aldehyde derivatives. Eur. J. Med. Chem. 1989, 24:313-315.
69. Rakesh, Sun D, Lee RB, Tangallapally RP, Lee RE. Synthesis, optimization and structure activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents. Eur. Med. Chem. 2009, 44: 460-472.
70. Rando DG, Sato DN, Siqueira L, Malvezzi A, Leite CQF, Amaral AT, Ferreira EI, Tavares LC. Potential tuberculostatic agents. Topliss application on benzoic acid [(5-Nitro-thiophen-2-yl)-methylene]-hydrazide series. Bioorg. Med. Chem. 2002, 10: 557-560.
71. Sacchettini JC, Rubin EJ, Freundlich JS. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat. Rev. Microbiol. 2008, 6: 41-52.
72. Sarangapani M, Reddy VM. Synthesis and antimicrobial activity of 1-[(N, N-disubstituted amino) methyl]-3-[(2-phenyl-3, 4-dihydro-4-oxoquinazoline-3-yl] indole-2-one. Indian J. Heterocycl. Chem. 1994, 3:257-260.
73. Sarciron ME, Audin P, Delebre I, Gabrion C, Petavy AF, Paris J. Synthesis of propargylic alcohols and biological effects on Echinococcus multilocularis metacestodes. J. Pharm. Sci. 1993, 82: 605-609.
74. Scior T, Garces-Eisele SJ. Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review. Curr. Med. Chem. 2006, 13: 2205-2219.
75. Scior T, Morales IM, Solón M, Eisel SG, Domeyer D, Laufer S. Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis - A Review. Arch. Pharm. Pharm. Med. Chem. 2002, 11:511-525.
76. Sethi ML 2002. Antiviral agents and protease inhibitors. In Principles of Medicinal Chemistry; Foye WO, Lemke TL, Williams DA, Eds.; Williams and Wilkins: Baltimore, p 952.
77. Silva PA, Anisa J. Drug and drug interaction. In Tuberculosis 2007. From Basic Science to Patient Care; Palomino JC, Leão SC, Ritacco V, Eds. 2007, pp. 593-633.
78. Singh SP, Shukla SK, Awasthi LP. Synthesis of some 3-(4′ -nitrobenzoylhydrazono)-2-indolinones as a potential antiviral agents. Curr. Sci. 1983, 52: 766-769.
79. Snider JDE, Castro KG. The global threat of drug-resistant tuberculosis. Eng. J. Med. 1998, 338:1689-1690.
80. Somu RV, Boshoff H, Qiao C, Bennett EM, Barry CE, Aldrich CC. Rationally Designed Nucleoside Antibiotics That Inhibit Siderophore Biosynthesis of Myco-bacterium tuberculosis. J. Med. Chem. 2006, 49: 31-34.
81. Sridhar SK, Pandeya SN, Stables JP, Ramesh A. The Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes. Eur. J. Med. Chem. 2002, 16: 129-132.
82. Sriram D, Aubry A, Yogeeswari P, Fisher LM. Gatifloxacin derivatives: Synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. Bioorg. Med. Chem. Lett. 2006, 16: 2982-2985.
83. Sriram D, Bal TR, Yogeeswari P, Radha DR, Nagaraja V. Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives. J. Gen. Appl. Microbiol. 2006, 52: 195-200.
84. Sriram D, Bal TR, Yogeeswari P. Aminopyrimidinimino isatin analogues: Design of novel nonnucleoside HIV-1 reverse transcriptase inhibitors with broad spectrum chemotherapeutic properties. J Pharm Pharmaceut Sci 2005, 8: 565-577.
85. Sriram D, Bal TR, Yogeeswari P. Design, Synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. Bioorg Med. Chem. 2004, 12: 5865-5873.
86. Sriram D, Bal TR, Yogeeswari P. Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation. Il Farmaco 2005, 60: 377-384.
87. Sriram D, Yogeeswari P, Basha JS, Radha DR, Nagaraja V. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorg. Med. Chem. 2005, 13: 5774-5778.
88. Sriram D, Yogeeswari P, Gopal G. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. Eur. J. Med. Chem. 2005, 40:1373-1376.
89. Sriram D, Yogeeswari P, Madhu K. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones. Bioorg. Med. Chem. Lett. 2005, 15: 4502-4505.
90. Sriram D, Yogeeswari P. Towards the design and development of agents with broad spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Curr. Med. Chem. 2003, 10:1689-1695.
91. Swamy BN, Suma TK, Rao GV, Reddy GC. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis. Eur. J. Med. Chem. 2007, 42: 420-424.
92. Székely R, Wáczek F, Szabadkai I, Németh G, Hegymegi-Barakonyi B, Eros D, Szokol B, Pató J, Hafenbradl D, Satchell J, Saint-Joanis B, Cole ST, Orfi L, Klebl BM, Kéri G. A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signaling. Immun. Lett. 2008, 116: 225-231.
93. Todeschini AR, Miranda ALP, Silva KCM, Parrini SC, Barreiro EJ. Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives. Eur. J. Med. Chem. 1998, 33: 189-199.
94. Tomioka H. Prospects for development of new antituberculous drugs. Kekkaku 2002, 77: 573-584, through Chem. Abstr. 2002, 138: 330985.
95. Varma M, Pandeya SN, Singh KN, Stables JP. Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharm. 2004, 54: 49-56.
96. Varma RS, Khan IA. Potential biologically active agents. X. Synthesis of 3-arylimino-2-indolinones, and their 1-methyl-and 1-morpholino/piperidinomethyl derivatives as excystment and cysticidal agents against Schizopyrenus russelli. From Polish journal of pharmacology and pharmacy 1977, 29: 549-594.
97. Varma RS, Nobles WL. Antiviral, antibacterial, and antifungal activities of isatin N-Mannich bases. J. Pharm. Sci. 1975, 64: 881-882.
98. Varma RS, Nobles WL. Synthesis and antiviral and antibacterial activity of certain N-dialkylaminomethylisatin beta-thiosemicarbazones. J. Med. Chem. 1967, 10: 972-974.
99. Vicini P, Zani F, Cozzini P, Doytchinova I. Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur. J. Med. Chem. 2002, 37: 553-564.
100. Wei L, Wang Q, Liu X. Application of thin-layer chromatography in quality control of Chinese medicinal preparations. II. Qualitative analysis of some Chinese medicinal preparations of Chansu. Yaowu Fenxi Zazhi 1982, 2: 288-291. (CA 98:95726b)
101. WHO. "Tuberculosis" Fact Sheet No 104, Health Communications, WHO,Geneva,2006.http://www.who.int/mediacentre/factsheets/fs104/en/index.html
102. Yan Y, Li G, Wang F, Mao W. Huadong Huagong Xueyuan Xuebao 1992, 18: 192. (CA 118:127985k)
103. Yepes JF, Sullivan J, Pinto A. Tuberculosis: medical manengment update. Medical manengment update. 2004, 98: 267-273.
104. Yoshikawa M, Murakami T, Kishi A, Sakurama T, Matsuda H, Nomura M, Kubo, M. Novel indole S,O-bisdesmoside, calanthoside, the precursor glycoside of tryptanthrin, indirubin, and isatin, with increasing skin blood flow promoting effects, from two Calanthe species (Orchidaceae). Chem. Pharm. Bull. 1998, 46: 886-888.
105. Zhou L, Liu Y, Zhang W, Wei P, Huang C, Pei J, Yuan Y, Lai L. Isatin Compounds as Noncovalent SARS Coronavirus 3C-like Proteasa Inhibitors. J. Med. Chem. 2006, 49: 3440-3443.